Abstract
Contrast induced acute kidney injury (CIAKI) is a known complication of percutaneous coronary intervention (PCI). Mehran Risk Score (MR score) has been previously shown to predict CIAKI, renal replacement therapy (RRT), and one-year mortality in patients undergoing PCI. The purpose of our study was to externally validate the MR score.
Highlights
Contrast-induced acute kidney injury (CIAKI) occurs in approximately 7% of patients undergoing percutaneous coronary intervention (PCI) [1]
A risk predicting score that helps in identifying patients at increased risk of developing Contrast induced acute kidney injury (CIAKI) may aid in targeted application of these therapies to better test their effectiveness
The MR score was calculated for each patient who were stratified into four groups: MR score 0-5, 6-10, 11-15, and ≥ 16
Summary
Contrast-induced acute kidney injury (CIAKI) occurs in approximately 7% of patients undergoing percutaneous coronary intervention (PCI) [1]. Despite identifying several risk factors and instituting preventive measures, PCI still remains a common cause of hospital-acquired acute kidney injury (AKI) [7]. To date no agent has proven to be effective in the prevention of CIAKI [8,9]. A risk predicting score that helps in identifying patients at increased risk of developing CIAKI may aid in targeted application of these therapies to better test their effectiveness. Contrast induced acute kidney injury (CIAKI) is a known complication of percutaneous coronary intervention (PCI). Mehran Risk Score (MR score) has been previously shown to predict CIAKI, renal replacement therapy (RRT), and one-year mortality in patients undergoing PCI. The purpose of our study was to externally validate the MR score
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
